ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,777Medicare Part D Prescriptions Filled, Including Refills

Rank: 13 out of 198

$776K Total Retail Price of All Prescriptions

Rank: 22 out of 198

707 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
24% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nebraska
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 707 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

16% of this provider’s 707 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

2% of this provider’s 14,828 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$46 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nebraska
SIMVASTATIN 887 800 1 2
LISINOPRIL 665 588 2 6
LEVOTHYROXINE SODIUM 647 606 3 1
AMLODIPINE BESYLATE 612 547 4 4
FUROSEMIDE 600 560 5 5
HYDROCODONE-ACETAMINOPHEN 525 416 S3 6 8
METOPROLOL SUCCINATE 480 445 7 11
OMEPRAZOLE 406 333 8 3
POTASSIUM CHLORIDE 343 320 9 9
WARFARIN SODIUM 309 300 10 7
CITALOPRAM HBR 271 241 11 20
METFORMIN HCL 251 230 12 13
METOPROLOL TARTRATE 248 224 13 10
ATENOLOL 242 227 14 17
GABAPENTIN 221 190 15 14
ATORVASTATIN CALCIUM 215 212 16 12
TRAMADOL HCL 199 177 17 15
PANTOPRAZOLE SODIUM 198 171 18 31
ALLOPURINOL 170 146 19 23
HYDROCHLOROTHIAZIDE 168 166 20 16
DONEPEZIL HCL 166 166 21 28
PREDNISONE 160 142 22 29
ZOLPIDEM TARTRATE 159 127 23 22
CRESTOR 154 116 24 26
CLONIDINE HCL 153 149 25 52
TAMSULOSIN HCL 143 134 26 27
FAMOTIDINE 142 106 27 57
CARVEDILOL 140 117 28 24
ALENDRONATE SODIUM 127 123 29 21
PRAVASTATIN SODIUM 124 107 30 19
LOSARTAN POTASSIUM 123 100 31 18
BENAZEPRIL HCL 119 106 32 45
TRAZODONE HCL 115 88 33 50
FLUTICASONE PROPIONATE 113 86 34 39
CLOPIDOGREL 107 79 35 42
NAMENDA 102 102 36 33
POLYETHYLENE GLYCOL 3350 99 83 37 41
AZITHROMYCIN 99 83 37 56
MIRTAZAPINE 95 79 39 44
AMOXICILLIN 93 76 40 130
LANTUS 90 75 41 46
LEVOFLOXACIN 88 82 42 81
GLIMEPIRIDE 87 87 43 35
SPIRONOLACTONE 87 77 43 37
CIPROFLOXACIN HCL 86 83 45 55
DIOVAN 85 84 46 34
TRIAMCINOLONE ACETONIDE 84 82 47 143
SERTRALINE HCL 84 81 47 25
TERAZOSIN HCL 84 84 47 102
ESCITALOPRAM OXALATE 83 78 50 53
NEXIUM 82 81 51 40
VESICARE 82 82 51 77
MELOXICAM 78 67 53 30
SULFAMETHOXAZOLE-TRIMETHOPRIM 75 71 54 90
GLYBURIDE 74 67 R 55 103
BYSTOLIC 73 55 56 58
CEPHALEXIN 71 66 57 108
DIGOXIN 69 57 58 43
SYNTHROID 68 67 59 36
PAROXETINE HCL 68 62 59 65
PLAVIX 68 50 59 66
LYRICA 66 49 62 91
DOXYCYCLINE HYCLATE 63 55 63 97
LIPITOR 59 49 64 116
BENICAR 58 50 65 100
GLIPIZIDE 58 54 65 62
FLUCONAZOLE 58 51 65 193
FLUOXETINE HCL 57 27 68 78
FENOFIBRATE 55 36 69 61
ADVAIR DISKUS 55 42 69 47
CARBIDOPA-LEVODOPA 54 54 71 71
ZETIA 54 52 71 68
ENALAPRIL MALEATE 54 54 71 51
PREMARIN 53 53 R 74 101
FINASTERIDE 52 52 75 94
BISOPROLOL-HYDROCHLOROTHIAZIDE 51 49 76 127
DILTIAZEM ER 51 51 76 98
HYDRALAZINE HCL 51 51 76 111
LOVASTATIN 50 46 79 70
TRIAMTERENE-HCTZ 50 48 79 32
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 19, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.